Clinical Trial Update: Adjuvant Cetuximab and Chemoradiotherapy Using Either Cisplatin or Docetaxel in Treating Patients With Resected Stage III or Stage IV Squamous Cell Carcinoma or Lymphoepithelioma of the Head and Neck [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating adjuvant cetuximab with chemoradiotherapy using either cisplatin or docetaxel in resected stage III/IV head and neck squamous cell carc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer
• Squamous Cell Carcinoma of the Head and Neck

Drugs mentioned

• CISPLATIN (cisplatin)
• Cetuximab (cetuximab)
• DOCETAXEL (DOCETAXEL)

Snippet

Sponsor: Radiation Therapy Oncology Group | Conditions: Head and Neck Cancer | Phase 2 | Status: COMPLETED | Results posted: 2016-11-22